Drugs / Asen
last change Sep 2020 re-read 2 minutes ago

Asen

Developed for
COVID-19
Investigated by
Institute for Research and Development of Medicinal and Food Plants of Guinea

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04502342 Jun → Aug 2020 COVID-19 Institute for Research and Development of Medicinal and Food Plants of Guinea Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Asen “triple treatment with Cospherunate, Asen and Azythromycine” NCT04502342